Liquidia Corporation Common Stock vs Nokia Corp — how do they compare? Liquidia Corporation Common Stock trades at $34.5 (market cap $2.40B), while Nokia Corp trades at $9.38 (market cap $54.54B). The key difference: Nokia Corp is far larger — about 22.7× Liquidia Corporation Common Stock's market cap, and Nokia Corp pays a 1.66% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nokia Corp for 65 Days on average.
| LQDA | NOK | |
|---|---|---|
Market Cap | $2.40B | $54.54B |
Volume | 2,857,547 | 76,721,489 |
Sector | Health | Technology |
52-Week High | $91.03 | $16.83 |
52-Week Low | $22.02 | $5.55 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $2.30B | $52.57B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nokia (NOK) trades at $9.86, down 0.4% on the day, with a bearish technical signal. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $19.89 billion with a net income margin of 3.47%. Recent news highlights partnerships in AI, satellite communications, and network automation, including an expanded collaboration with Microsoft announced on September 17, 2026.
The outlook is cautiously optimistic, supported by strong analyst buy ratings (59.6%) and a consensus price target of $17.50, implying significant upside. Key opportunities include growth in AI and cloud infrastructure demand, while risks involve competitive pressures and inconsistent earnings performance. Cash flow volatility remains a concern, with net cash flow negative in 2025 and 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →